TechInvest News

Asia Expansion Accelerates For Medical Device Producer - TechInvest Magazine Online

Written by Kira Friedman | Oct 1, 2019 9:17:48 AM

One of the world’s greatest financial centres, Hong Kong, has just been the centre of celebration for US-based medical device company Visioneering Technologies, Inc (ASX: VTI).

Visioneering Technologies is the producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses (NVMF) and it’s just recorded its first sale in Asia.

The Company’s NVMF lens has been fit and dispensed to the first several patients in Hong Kong by Hong Kong optometrist and Hong Kong Polytechnic University graduate Forrest Ng, Bsc (Honors) Optom, PhD, FAAO.

“I’m very pleased to be able to bring this unique technology into Hong Kong. Not only have the lenses been shown to be useful in slowing myopia progression in children, but they also can provide excellent near and distance vision in presbyopic adults,” Dr Forrest Ng said.

A specialist in the management of paediatric myopia, Dr Ng is not only a graduate and guest lecturer at Hong Kong Polytechnic University, but also a Fellow of the American Academy of Optometry. As a founding member of Eyesight Optometry Center Hong Kong and Registered Optometrist (Part 1), Dr Ng has been seeing paediatric patients in practice since 2002.

Visioneering Technologies sales mark entry into Asia by Visioneering’s revolutionary NVMF contact lenses, which are used on nearsighted children (paediatric myopia) and on over-40 adults who are losing the ability to see things up close (presbyopia).

“Our first sales in Hong Kong are a significant milestone for the Company, representing a jump-off for VTI’s expansion into Asia. The incidence of paediatric myopia is at a critical level in Asia, and given the correlation between myopia and other serious ocular diseases, solutions to myopia progression are desperately needed,” said Visioneering CEO Dr Stephen Snowdy.

Visioneering identified Hong Kong as a target market as Hong Kong has a strong need for myopia management solutions. Researchers estimate that over 25% of 5-9-year-olds in Hong Kong are myopic and that, as the condition worsens throughout adolescence, over 90% of 20-24-year-olds have myopia.

With limited soft contact lens options available to manage paediatric myopia, I’m happy to use Visioneering’s NaturalVue Multifocal 1 Day Contact Lenses as an option for nearsighted children,” Dr Forrest Ng said.

Hong Kong will act as a springboard for VTI’s further expansion in Asia, with Korea, Southeast Asia, Japan, and China all representing attractive markets for myopia progression control products.

VTI is proud to offer what we feel is an excellent solution to sufferers of paediatric myopia in Hong Kong, and looks forward to its continued expansion in Asia,” said Visioneering CEO Dr Stephen Snowdy.